Could Changing the THC/CBD Ratio in Cannabis Reduce Its Harms? | Research

The takeaway

A commentary argued that public health interventions should target specific drug-related harms rather than prohibit use, suggesting that reducing THC and increasing CBD content in cannabis could lower psychosis and addiction risk.

Read this if you are interested in cannabis policy and harm reduction approaches.

Reducing THC and increasing CBD in cannabis could reduce psychosis and addiction risk

What the researchers found

This commentary made two specific harm-reduction proposals:

For alcohol: adding dissolved oxygen could reduce accident risk and liver damage.

For cannabis: strong evidence indicated that reducing THC content and increasing CBD content could reduce the risk of psychosis and addiction associated with cannabis use.

The author argued that public health interventions should focus on reducing concrete harms rather than making moral judgments about which human experiences should or should not be enhanced through substance use.

The central proposition was that responsible regulation should not be limited to preventing or reducing use, but should include strategies to reduce the burden of illness associated with substance use.

Why it matters

This commentary articulated a regulatory philosophy that has gained traction: rather than debating whether people should use cannabis, focus on making the available products less harmful through compositional standards.

The numbers in context

Two substances discussed: alcohol (dissolved oxygen proposal) and cannabis (THC reduction, CBD increase). Evidence cited for CBD reducing psychosis and addiction risk.

How the study worked

Commentary/editorial presenting evidence-based harm reduction proposals for alcohol and cannabis, arguing for regulatory approaches focused on specific harm reduction.

What this study cannot tell us

Commentary piece rather than original research. The practical feasibility of regulating cannabis composition was not fully addressed. The dissolved oxygen/alcohol proposal had limited evidence.

How to read the evidence

Expert commentary informed by existing evidence. Proposes regulatory approaches rather than presenting new data.

When this study was published

Published in 2010. Cannabis potency regulation and CBD requirements have since become active policy discussions in many jurisdictions.

The bigger picture

As cannabis legalization has expanded, the idea of regulating cannabis composition (THC limits, minimum CBD requirements) has become increasingly relevant. This 2010 commentary was ahead of its time in proposing evidence-based product standards.

Questions still open

Should legal cannabis markets mandate maximum THC or minimum CBD levels? Would consumers accept regulated composition products? Could compositional standards be enforced effectively?

Common questions

Could changing the THC/CBD ratio make cannabis safer?

Research supports this idea. Higher-THC, lower-CBD cannabis has been associated with greater psychosis risk and dependence. Products with balanced or higher CBD content appear to carry lower risk for these outcomes.

Why not just ban cannabis instead?

The author argued that prohibition has not prevented cannabis use and creates additional harms (criminalization, unregulated markets). Regulation that focuses on reducing specific harms through product composition could be more effective than prohibition.

Read the original research

Enhancement drugs: are there limits to what we should enhance and why?

BMC medicine, 8, 50

View on PubMed ↗Publisher’s paper ↗

Citation

Hesse, Morten. (2010). Enhancement drugs: are there limits to what we should enhance and why?. BMC medicine, 8, 50. https://doi.org/10.1186/1741-7015-8-50